Loading...
Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from India
BACKGROUND: This post hoc analysis evaluated the efficacy and safety of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus (T2DM) from India. METHODS: Changes from baseline in HbA(1c), fasting plasma glucose (FPG), body weight, and blood pressure (B...
Na minha lista:
| Udgivet i: | Indian J Endocrinol Metab |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Medknow Publications & Media Pvt Ltd
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4855968/ https://ncbi.nlm.nih.gov/pubmed/27186557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.179996 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|